Literature DB >> 30442826

Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis.

Amanda M Eudy1,2, Gary McDaniel3,4, William W Hurd3,4, Megan E B Clowse3,4.   

Abstract

OBJECTIVE: We sought to identify causes for infertility in women with and without rheumatoid arthritis (RA).
METHODS: Women with RA were matched to healthy controls. Differences in anti-Müllerian hormone (AMH) and anovulation were analyzed.
RESULTS: Women with RA had lower AMH (β -1.05, 95% CI -2.09 to -0.005), but no difference was observed when AMH was log-transformed. No difference in anovulation was observed. Infertility prevalence was similar between groups, primarily attributable to polycystic ovary syndrome in healthy controls but largely unexplained in women with RA.
CONCLUSION: AMH was lower in women with RA, but reasons for infertility among women with RA remain unknown.

Entities:  

Keywords:  ANTI–MÜLLERIAN HORMONE; FERTILITY; PROGESTERONE; RHEUMATOID ARTHRITIS

Mesh:

Substances:

Year:  2018        PMID: 30442826     DOI: 10.3899/jrheum.180176

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Association between arthritis treatments and ovarian reserve: a prospective study.

Authors:  Vinita M Alexander; Jillian Ashley-Martin; Joan K Riley; Amber R Cooper; Valerie S Ratts; Emily S Jungheim
Journal:  Reprod Biomed Online       Date:  2021-03-31       Impact factor: 4.567

2.  Evaluation of Ovarian Reserve in Women With Rheumatoid Arthritis.

Authors:  Sara Patricia Peña-Lizola; Luis Humberto Sordia-Hernandez; Selene Marysol Garcia-Luna; Otto Valdes-Martinez; Cassandra Michele Skinner-Taylor; Mario Alberto Garza-Elizondo; Oscar Vidal-Gutierrez; Jesus Zacarias Villarreal-Perez; Miryam Eguia-Bernal; Felipe Arturo Morales-Martinez
Journal:  J Family Reprod Health       Date:  2021-12

Review 3.  Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.

Authors:  Loes M E Moolhuijsen; Jenny A Visser
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.